{"entity":{"type":"insider","cik":"0001400975","url":"/insider/0001400975","json_url":"/insider/0001400975.json","name":"Weinhoff Gregory M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":23,"n_filings":19,"first":"2008-08-18","last":"2026-03-26","span_basis":"filed_date"},"name_variants":[{"name":"Weinhoff Gregory M","source":"filing","n_filings":19,"first_seen":"2008-08-18","last_seen":"2026-03-26"}],"transactions":[{"id":5755751,"accession":"0001470831-26-000320","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-26-000320","line_url":"/filing/0001470831-26-000320#line-2","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23998.0,"shares_display":"23,998","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":719940.0,"total_display":"719,940.00","shares_owned_after":65925.0,"shares_owned_after_display":"65,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-26","filed_date":"2026-03-26","scope":"insider"},{"id":6148057,"accession":"0001470831-26-000267","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001470831-26-000267","line_url":"/filing/0001470831-26-000267#line-2","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":61253.0,"shares_display":"61,253","price_per_share":26.1668,"price_display":"26.17","price_state":"stated","total_value":1602795.0004,"total_display":"1,602,795.00","shares_owned_after":77868.0,"shares_owned_after_display":"77,868","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-13","filed_date":"2026-03-13","scope":"insider"},{"id":6148053,"accession":"0001470831-26-000267","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001470831-26-000267","line_url":"/filing/0001470831-26-000267#line-1","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11943.0,"shares_display":"11,943","price_per_share":27.157,"price_display":"27.16","price_state":"stated","total_value":324336.051,"total_display":"324,336.05","shares_owned_after":65925.0,"shares_owned_after_display":"65,925","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-13","filed_date":"2026-03-13","scope":"insider"},{"id":4561924,"accession":"0001847903-25-000123","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000123","line_url":"/filing/0001847903-25-000123#line-2","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.5598,"price_display":"15.56","price_state":"stated","total_value":155598.0,"total_display":"155,598.00","shares_owned_after":122279.0,"shares_owned_after_display":"122,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-25","filed_date":"2025-07-25","scope":"insider"},{"id":4447162,"accession":"0001847903-25-000115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000115","line_url":"/filing/0001847903-25-000115#line-2","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":13.8642,"price_display":"13.86","price_state":"stated","total_value":138642.0,"total_display":"138,642.00","shares_owned_after":122279.0,"shares_owned_after_display":"122,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-25","filed_date":"2025-06-25","scope":"insider"},{"id":5221160,"accession":"0001847903-25-000078","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000078","line_url":"/filing/0001847903-25-000078#line-2","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":12.8225,"price_display":"12.82","price_state":"stated","total_value":128225.0,"total_display":"128,225.00","shares_owned_after":122279.0,"shares_owned_after_display":"122,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-27","filed_date":"2025-05-27","scope":"insider"},{"id":4779425,"accession":"0001847903-25-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-25-000059","line_url":"/filing/0001847903-25-000059#line-1","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11742.0,"shares_display":"11,742","price_per_share":13.6141,"price_display":"13.61","price_state":"stated","total_value":159856.7622,"total_display":"159,856.76","shares_owned_after":122279.0,"shares_owned_after_display":"122,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-25","filed_date":"2025-04-25","scope":"insider"},{"id":4971956,"accession":"0001847903-25-000053","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-25-000053","line_url":"/filing/0001847903-25-000053#line-2","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.3386,"price_display":"16.34","price_state":"stated","total_value":163386.0,"total_display":"163,386.00","shares_owned_after":134021.0,"shares_owned_after_display":"134,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-25","filed_date":"2025-03-26","scope":"insider"},{"id":4934227,"accession":"0001847903-25-000037","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-25-000037","line_url":"/filing/0001847903-25-000037#line-1","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11494.0,"shares_display":"11,494","price_per_share":15.2488,"price_display":"15.25","price_state":"stated","total_value":175269.7072,"total_display":"175,269.71","shares_owned_after":134021.0,"shares_owned_after_display":"134,021","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-25","filed_date":"2025-02-26","scope":"insider"},{"id":4934222,"accession":"0001847903-25-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-25-000013","line_url":"/filing/0001847903-25-000013#line-1","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11742.0,"shares_display":"11,742","price_per_share":16.4733,"price_display":"16.47","price_state":"stated","total_value":193429.4886,"total_display":"193,429.49","shares_owned_after":159782.0,"shares_owned_after_display":"159,782","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-27","filed_date":"2025-01-28","scope":"insider"},{"id":2333637,"accession":"0001847903-24-000188","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-24-000188","line_url":"/filing/0001847903-24-000188#line-2","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":17.0399,"price_display":"17.04","price_state":"stated","total_value":170399.0,"total_display":"170,399.00","shares_owned_after":183266.0,"shares_owned_after_display":"183,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-26","filed_date":"2024-12-26","scope":"insider"},{"id":2809748,"accession":"0001847903-24-000173","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-24-000173","line_url":"/filing/0001847903-24-000173#line-2","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":17.6601,"price_display":"17.66","price_state":"stated","total_value":176601.0,"total_display":"176,601.00","shares_owned_after":183266.0,"shares_owned_after_display":"183,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-25","filed_date":"2024-11-27","scope":"insider"},{"id":2495120,"accession":"0001847903-24-000162","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-24-000162","line_url":"/filing/0001847903-24-000162#line-1","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11742.0,"shares_display":"11,742","price_per_share":15.3831,"price_display":"15.38","price_state":"stated","total_value":180628.3602,"total_display":"180,628.36","shares_owned_after":183266.0,"shares_owned_after_display":"183,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-25","filed_date":"2024-10-25","scope":"insider"},{"id":2495104,"accession":"0001847903-24-000147","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-24-000147","line_url":"/filing/0001847903-24-000147#line-1","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16619.0,"shares_display":"16,619","price_per_share":15.6883,"price_display":"15.69","price_state":"stated","total_value":260723.8577,"total_display":"260,723.86","shares_owned_after":206750.0,"shares_owned_after_display":"206,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-25","filed_date":"2024-09-27","scope":"insider"},{"id":2072503,"accession":"0001847903-24-000143","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-24-000143","line_url":"/filing/0001847903-24-000143#line-2","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":510000.0,"total_display":"510,000.00","shares_owned_after":223369.0,"shares_owned_after_display":"223,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-10","filed_date":"2024-09-12","scope":"insider"},{"id":2445865,"accession":"0001847903-24-000139","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-24-000139","line_url":"/filing/0001847903-24-000139#line-2","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":375000.0,"total_display":"375,000.00","shares_owned_after":223369.0,"shares_owned_after_display":"223,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-09-09","filed_date":"2024-09-09","scope":"insider"},{"id":2874987,"accession":"0001847903-24-000135","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-24-000135","line_url":"/filing/0001847903-24-000135#line-2","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17802.0,"shares_display":"17,802","price_per_share":12.2903,"price_display":"12.29","price_state":"stated","total_value":218791.9206,"total_display":"218,791.92","shares_owned_after":223369.0,"shares_owned_after_display":"223,369","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-23","scope":"insider"},{"id":2874982,"accession":"0001847903-24-000135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-24-000135","line_url":"/filing/0001847903-24-000135#line-1","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Business Officer)","officer_title":"Chief Business Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12198.0,"shares_display":"12,198","price_per_share":12.1684,"price_display":"12.17","price_state":"stated","total_value":148430.1432,"total_display":"148,430.14","shares_owned_after":241171.0,"shares_owned_after_display":"241,171","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-22","filed_date":"2024-08-23","scope":"insider"},{"id":6379614,"accession":"0001847903-22-000066","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001847903-22-000066","line_url":"/filing/0001847903-22-000066#line-2","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4901.0,"shares_display":"4,901","price_per_share":3.9501,"price_display":"3.95","price_state":"stated","total_value":19359.4401,"total_display":"19,359.44","shares_owned_after":231099.0,"shares_owned_after_display":"231,099","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-03","filed_date":"2022-10-04","scope":"insider"},{"id":6379610,"accession":"0001847903-22-000066","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001847903-22-000066","line_url":"/filing/0001847903-22-000066#line-1","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":4.0674,"price_display":"4.07","price_state":"stated","total_value":16269.6,"total_display":"16,269.60","shares_owned_after":236000.0,"shares_owned_after_display":"236,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-30","filed_date":"2022-10-04","scope":"insider"},{"id":5132008,"accession":"0000899243-21-022063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-022063","line_url":"/filing/0000899243-21-022063#line-1","is_derivative":false,"issuer_cik":"0001400975","issuer_name":"Centessa Pharmaceuticals plc","issuer_ticker":"CNTA","issuer_name_source":null,"issuer_url":"/issuer/0001400975","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Ordinary Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-02","filed_date":"2021-06-04","scope":"insider"},{"id":3879650,"accession":"0001400975-08-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001400975-08-000001","line_url":"/filing/0001400975-08-000001#line-2","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46844.0,"shares_display":"46,844","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":796348.0,"total_display":"796,348.00","shares_owned_after":1928612.0,"shares_owned_after_display":"1,928,612","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-14","filed_date":"2008-08-18","scope":"insider"},{"id":3879648,"accession":"0001400975-08-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001400975-08-000001","line_url":"/filing/0001400975-08-000001#line-1","is_derivative":false,"issuer_cik":"0001178879","issuer_name":"AMICUS THERAPEUTICS INC","issuer_ticker":"FOLD","issuer_name_source":null,"issuer_url":"/issuer/0001178879","owner_cik":"0001400975","owner_name":"Weinhoff Gregory M","owner_url":"/insider/0001400975","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3156.0,"shares_display":"3,156","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":53652.0,"total_display":"53,652.00","shares_owned_after":129943.0,"shares_owned_after_display":"129,943","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-08-14","filed_date":"2008-08-18","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":23,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":22,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":23},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001847903","name":"Centessa Pharmaceuticals plc","url":"/issuer/0001847903","role":"Officer (Chief Business Officer)","n_filings":18,"first_seen":"2021-06-04","last_seen":"2026-03-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001178879","name":"AMICUS THERAPEUTICS INC","url":"/issuer/0001178879","role":"Director","n_filings":1,"first_seen":"2008-08-18","last_seen":"2008-08-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001400975","retrieved_at":"2026-08-21T23:35:05+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}